Internet Archive Scholar

Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines [post]

Ioana Agache, Yang Song, Margarita Posso, Pablo Alonso Coello, Claudio Rocha, Ivan Sola, Jessica Beltran, Cezmi Akdis, Mubeccel Akdis, Knut Brockow, T Chivato, Stefano R Del Giacco (+14 others)
2020 unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (237.6 kB)
https://web.archive.org/web/20220521130019/https://d197for5662m48.cloudfront.net/documents/publicationstatus/42136/preprint_pdf/2d46317628c8b8c2dc82bcbd05f495c3.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

This systematic review evaluates the efficacy, safety and economic impact of dupilumabcompared to standard of care for
doi:10.22541/au.159423110.06430562 fatcat:oqbawviu7remvoqy5zej3jr3q4
Citation

Ioana Agache, Yang Song, Margarita Posso, Pablo Alonso Coello, Claudio Rocha, Ivan Sola, Jessica Beltran, Cezmi Akdis, Mubeccel Akdis, Knut Brockow, T Chivato, Stefano R Del Giacco, Thomas Eiwegger, Kilian Eyerich, Ana Gim nez Arnau, Jan Gutermuth, Emma Guttmann Yassky, Marcus Maurer, Graham Ogg, Peck Ong, Liam O Mahony, J rgen Schwarze, Thomas Werfel, Carlos Canelo Aybar, Oscar Palomares, Marek Jutel. "Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines." (2020)